FASN inhibition leads to a decrease in tumor progression through several mechanisms, such as alteration of plasma membrane structure, an increase in cancer cell apoptosis, decrease in palmitate synthesis, and inhibition of Wnt, Akt, and β-catenin oncogenic signaling pathways [122]. Here, FASN is linked to cancer.